The New Paradigm of Precision Medicine for the Management of Advanced Systemic Mastocytosis

Download All
Learn how experts are integrating targeted therapies into the management of their patients with advanced systemic mastocytosis, including focused commentaries, a multidisciplinary podcast featuring case discussions, and a text module with downloadable slides.
Prithviraj Bose, MD
Daniel J. DeAngelo, MD, PhD


Advanced systemic mastocytosis is a rare diagnosis, yet treatment options are increasing with new FDA approvals. In this commentary, I review current treatments and the most clinically important studies on advanced systemic mastocytosis from ASH 2021.

Daniel J. DeAngelo, MD, PhD Released: February 18, 2022

Despite the rarity of systemic mastocytosis, multiple therapies are available to manage advanced disease. In this commentary, I review key data on current treatment options and how I individualize therapy for patients with advanced systemic mastocytosis.

Prithviraj Bose, MD Released: April 21, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Blueprint Medicines

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings